485 related articles for article (PubMed ID: 21123952)
1. Advances and challenges in malaria vaccine development.
Crompton PD; Pierce SK; Miller LH
J Clin Invest; 2010 Dec; 120(12):4168-78. PubMed ID: 21123952
[TBL] [Abstract][Full Text] [Related]
2. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
3. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
[TBL] [Abstract][Full Text] [Related]
4. Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum.
Duffy PE; Krzych U; Francis S; Fried M
Vaccine; 2005 Mar; 23(17-18):2235-42. PubMed ID: 15755603
[TBL] [Abstract][Full Text] [Related]
5. Vaccines against malaria.
Ouattara A; Laurens MB
Clin Infect Dis; 2015 Mar; 60(6):930-6. PubMed ID: 25452593
[TBL] [Abstract][Full Text] [Related]
6. Development of the RTS,S/AS malaria candidate vaccine.
Vekemans J; Leach A; Cohen J
Vaccine; 2009 Dec; 27 Suppl 6():G67-71. PubMed ID: 20006143
[TBL] [Abstract][Full Text] [Related]
7. Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
Ellis RD; Sagara I; Doumbo O; Wu Y
Hum Vaccin; 2010 Aug; 6(8):627-34. PubMed ID: 20519960
[TBL] [Abstract][Full Text] [Related]
8. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
[TBL] [Abstract][Full Text] [Related]
9. The Delay in the Licensing of Protozoal Vaccines: A Comparative History.
Palatnik-de-Sousa CB; Nico D
Front Immunol; 2020; 11():204. PubMed ID: 32210953
[TBL] [Abstract][Full Text] [Related]
10. Pfs230: from malaria transmission-blocking vaccine candidate toward function.
Williamson KC
Parasite Immunol; 2003 Jul; 25(7):351-9. PubMed ID: 14521577
[No Abstract] [Full Text] [Related]
11. Overview: immunology of malaria and progress in malaria vaccine development.
Tharavanij S
Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
[No Abstract] [Full Text] [Related]
12. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
Mahmoudi S; Keshavarz H
Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
[TBL] [Abstract][Full Text] [Related]
13. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
[TBL] [Abstract][Full Text] [Related]
14. The hope but challenge for developing a vaccine that might control malaria.
Good MF
Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585
[TBL] [Abstract][Full Text] [Related]
15. Malaria vaccine development: lessons from the field.
Todryk S; Bejon P
Eur J Immunol; 2009 Aug; 39(8):2007-10. PubMed ID: 19672893
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.
Palacpac NM; Arisue N; Tougan T; Ishii KJ; Horii T
Vaccine; 2011 Aug; 29(35):5837-45. PubMed ID: 21718740
[TBL] [Abstract][Full Text] [Related]
17. Vaccine candidate discovery for the next generation of malaria vaccines.
Tuju J; Kamuyu G; Murungi LM; Osier FHA
Immunology; 2017 Oct; 152(2):195-206. PubMed ID: 28646586
[TBL] [Abstract][Full Text] [Related]
18. Malaria vaccine based on self-assembling protein nanoparticles.
Burkhard P; Lanar DE
Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
[TBL] [Abstract][Full Text] [Related]
19. The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine.
Chen Q
Microbes Infect; 2007 May; 9(6):777-83. PubMed ID: 17398133
[TBL] [Abstract][Full Text] [Related]
20. The case for a subunit vaccine against malaria.
Anders RF
Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
